Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM. Kirk AD, et al. Among authors: celniker a. Transplantation. 2001 Aug 15;72(3):377-84. doi: 10.1097/00007890-200108150-00005. Transplantation. 2001. PMID: 11502964
Antibody-based therapeutics in oncology.
Ross J, Gray K, Schenkein D, Greene B, Gray GS, Shulok J, Worland PJ, Celniker A, Rolfe M. Ross J, et al. Among authors: celniker a. Expert Rev Anticancer Ther. 2003 Feb;3(1):107-21. doi: 10.1586/14737140.3.1.107. Expert Rev Anticancer Ther. 2003. PMID: 12597355 Review.
Measurement of human interleukin 11.
Bennett F, Gianotti J, Celniker A, Turner KJ, Clark SC. Bennett F, et al. Among authors: celniker a. Curr Protoc Immunol. 2001 May;Chapter 6:6.15.1-6.15.12. doi: 10.1002/0471142735.im0615s18. Curr Protoc Immunol. 2001. PMID: 18432806
A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis.
Goldstein MH, Tubridy KL, Agahigian J, Furfine E, Magill M, Kovalchin J, Golden K, Zarbis-Papastoitsis G, Soong F, Salapatek AM, Sternberg G, Celniker A. Goldstein MH, et al. Among authors: celniker a. Eye Contact Lens. 2015 May;41(3):145-55. doi: 10.1097/ICL.0000000000000152. Eye Contact Lens. 2015. PMID: 25915834 Clinical Trial.
Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.
Smolec J, DeSilva B, Smith W, Weiner R, Kelly M, Lee B, Khan M, Tacey R, Hill H, Celniker A, Shah V, Bowsher R, Mire-Sluis A, Findlay JW, Saltarelli M, Quarmby V, Lansky D, Dillard R, Ullmann M, Keller S, Karnes HT. Smolec J, et al. Among authors: celniker a. Pharm Res. 2005 Sep;22(9):1425-31. doi: 10.1007/s11095-005-5917-9. Epub 2005 Aug 24. Pharm Res. 2005. PMID: 16132353 Review.
27 results